Seely Lynn - Insider Non-Derivative Transactions at Lyell Immunopharma, Inc. (LYEL) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 10, 2025, Seely Lynn's relationship to Lyell Immunopharma, Inc. (LYEL) is Director,Officer (President and CEO), and currently has 67,159 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other LYEL insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Seely Lynn - Insider Non-Derivative Transactions of LYEL Common Stock

Seely Lynn - Insider Non-Derivative Transactions at LYEL

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 11, 2025	Sell -- (Common Stock)	412	16.11	67159
Aug 22, 2025	Sell -- (Common Stock)	7257	10.54	67571
Aug 21, 2025	Acquisition -- (Common Stock)	40000	0	74828
Aug 13, 2025	Sell -- (Common Stock)	406	10.34	34828
Aug 12, 2025	Sell -- (Common Stock)	391	10.53	35234
Mar 15, 2025	P -- (Common Stock)	175000	0.61	712500
Feb 11, 2025	Acquisition -- (Common Stock)	337500	0	537500
Feb 10, 2024	Acquisition -- (Common Stock)	200000	0	200000